What makes P450s work? Searches for answers with known and new P450s

Drug Metabolism Reviews

Volumn 32, Issue 3-4, 2000, Pages 267-281

  Guengerich, F Peter ^a   Parikh, Asit ^a   Yun, Chul Ho ^a   Kim, Donghak ^a   Nakamura, Katsunori ^a   Notley, Lisa M ^b   Gillam, Elizabeth M J ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cytochrome P450; Heterocyclic amines; Indigo; Indole; Phenacetin; Random mutagensis

Indexed keywords

CYTOCHROME P450; PHENACETIN;

CONFERENCE PAPER; DRUG METABOLISM; DRUG OXIDATION; ENZYME ACTIVITY; GENE MUTATION; HUMAN; STRUCTURE ACTIVITY RELATION;

CYTOCHROME P-450 CYP1A2; ENZYME INHIBITORS; HUMANS; INDIGOTINDISULFONATE SODIUM; LAC OPERON; MUTAGENESIS; OXIDATION-REDUCTION; PHENACETIN;

EID: 0034538812     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.1081/DMR-100102334     Document Type: Conference Paper

References (42)

1. M. J. Coon, X. Ding, S. J. Pernecky, and A. D. N. Vaz, Cytochrome P450: Progress and predictions, FASEB J., 6, 669-673 (1992).
2. P. R. Ortiz de Montellano (ed.), Cytochrome P450: Structure, Mechanism, and Biochemistry, 2nd ed., Plenum Press, New York, 1995.
3. F. P. Guengerich, Human cytochrome P450 enzymes, in Cytochrome P450, 2nd ed. (P. R. Ortiz de Montellano, ed.), Plenum Press, New York, 1995, pp. 473-535.
4. F. P. Guengerich, Reactions and significance of cytochrome P-450 enzymes, J. Biol. Chem., 266, 10,019-10,022 (1991).
5. cam research: Mechanistic insights into oxygenase catalysis, in Cytochrome P450: Structure, Mechanism, and Biochemistry, 2nd ed. (P. R. Ortiz de Montellano, ed.), Plenum Press, New York, 1995, pp. 83-124.
6. W. H. Bradshaw, H. E. Conrad, E. J. Corey, I. C. Gunsalus, and D. Lednicer, Degradation of (+)-camphor, J. Am. Chem. Soc., 81, 5007 (1959).
7. terp at 2.3 Å resolution, J. Molec. Biol., 236, 1169-1185 (1994).
8. BM-3 and other inducible bacterial P450 cytochromes: Biochemistry and regulation, Annu. Rev. Pharmacol. Toxicol., 31, 177-203 (1991).
9. G. Hosny, L. J. Roman, M. H. Mostafa, and B. S. S. Masters, Unique properties of purified, Escherichia coli-expressed constitutive cytochrome P4504A5, Arch. Biochem. Biophys., 366, 199-206 (1999).
10. L. C. Bell and F. P. Guengerich, Oxidation kinetics of ethanol by human cytochrome P450 2E1. Rate-limiting product release accounts for effects of isotopic hydrogen substitution and cytochrome b5 on steady-state kinetics, J. Biol. Chem., 272, 29,643-29,651 (1997).
11. L. C. Bell-Parikh and F. P. Guengerich, Kinetics of cytochrome P450 2E1-catalyzed oxidation of ethanol to acetic acid via acetaldehyde, J. Biol. Chem., 274, 23,833-23,840 (1999).
12. P. R. Ortiz de Montellano, Oxygen activation and reactivity, in Cytochrome P450: Structure, Mechanism, and Biochemistry, 2nd ed. (P. R. Ortiz de Montellano, ed.), Plenum Press, New York, 1995, pp. 245-303.
13. S. G. Sligar and S. Maves, A unified mechanism of oxygen activation as determined by cryocrystallography, Abstracts, 9th North American Meeting. Int. Soc. Study Xenobiotics/Amer. Chem. Soc. - Div. Chem. Toxicol., Nashville, October 1999, p. 15.
14. J. D. Hermes, S. C. Blacklow, and J. R. Knowles, Searching sequence space by definably random mutagenesis: Improving the catalytic potency of an enzyme, Proc. Natl. Acad. Sci. USA, 87, 696-700 (1990).
15. K. Chen and F. H. Arnold, Enzyme engineering for nonaqueous solvents: Random mutagenesis to enhance activity of subtilisin E in polar organic media, Bio/Technology, 9, 1073-1077 (1991).
16. R. Laine and P. R. Ortiz de Montellano, Directed evolution of the P450cam specificity, FASEB J., 11, A811 (1997).
17. C. W. Fisher, M. S. Shet, K. M. Faulkner, and R. W. Estabrook, A visual screening method for identification of functional mutants of recombinant P450 1A2, Abstracts, 11th Int. Sympos. Microsomes and Drug Oxidations. Los Angeles, July 1996, p. 222.
18. G. R. Harlow and J. R. Halpert, Alanine-scanning mutagenesis of a putative substrate recognition site in human cytochrome P450 3A4: Role of residues 210 and 211 in flavonoid activation and substrate specificity, J. Biol. Chem., 272, 5396-5402 (1997).
19. M-S. Dong, L. C. Bell, Z. Guo, D. R. Phillips, I. A. Blair, and F. P. Guengerich, Identification of retained N-formylmethionine in bacterial recombinant cytochrome P450 proteins with the N-terminal sequence MALLLAVFL . . .: Roles of residues 3-5 in retention and membrane topology, Biochemistry, 35, 10,031-10,040 (1996).
20. S. A. Maves and S. G. Sligar, Directed evolution of cytochrome P450 thermostability, Abstracts, 11th Int. Meetg. Cytochrome P450, 29 August-2 September, Sendai, p. 118 (1999).
21. A. Parikh and F. P. Guengerich, Expression, purification, and characterization of a catalytically active human cytochrome P450 1A2:NADPH-cytochrome P450 reductase fusion protein, Protein Express. Purif. 9, 346-354 (1997).
22. M-S. Dong, H. Yamazaki, Z. Guo, and F. P. Guengerich, Recombinant human cytochrome P450 1A2 and an N-terminal truncated form: Construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase, Arch. Biochem. Biophys., 327, 11-19 (1996).
23. A. Parikh, E. M. J. Gillam, and F. P. Guengerich, Drug metabolism by Escherichia coli expressing human cytochromes P450, Nature Biotechnol., 15, 784-788 (1997).
24. O. Gotoh, Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analysis of amino acid and coding nucleotide sequences, J. Biol. Chem., 267, 83-90 (1992).
25. A. Parikh and F. P. Guengerich, Random mutagenesis via whole plasmid PCR amplification, BioTechniques, 24, 428-431 (1998).
26. P. D. Josephy, D. H. Evans, A. Parikh, and F. P. Guengerich, Metabolic activation of aromatic amine mutagens by simultaneous expression of human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and N-acetyltransferase in Escherichia coli, Chem. Res. Toxicol., 11, 70-74 (1998).
27. A. Parikh, P. D. Josephy, and F. P. Guengerich, Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties, Biochemistry, 38, 5283-5289 (1999).
28. F. P. Guengerich, Analysis and characterization of enzymes, in Principles and Methods of Toxicology (A. W. Hayes, ed.), Raven Press, New York, 1994, pp. 1259-1313.
29. F. P. Guengerich, L. A. Peterson, and R. H. Böcker, Cytochrome P-450-catalyzed hydroxylation and carboxylic acid ester cleavage of Hantzsch pyridine esters, J. Biol. Chem., 263, 8176-8183 (1988).
30. A. D. N. Vaz and M. J. Coon, On the mechanism of action of cytochrome P450: Evaluation of hydrogen abstraction in oxygen-dependent alcohol oxidation, Biochemistry, 33, 6442-6449 (1994).
31. H. Joo, Z. L. Lin, and F. H. Arnold, Laboratory evolution of peroxide-mediated cytochrome P450 hydroxylation, Nature, 399, 670-673 (1999).
32. H. Joo, A. Arisawa, Z. Lin, and F. H. Arnold, A high-throughput digital imaging screen for the discovery and directed evolution of oxygenases, Chem. Biol., 6, 699-706 (1999).
33. P. Aryal, K. Yoshikawa, T. Terashita, F. P. Guengerich, T. Shimada, and Y. Oda, Development of a new genotoxicity test system with Salmonella typhimurium OY1001/1A2 expressing human cytochrome P450 1A2 and NADPH-cytochrome P450 reductase, Mutat. Res., 442, 113-120 (1999).
34. T. Shimada, Y. Oda, H. Yamazaki, M. Mimura, and F. P. Guengerich, SOS function tests for studies of chemical carcinogenesis in Salmonella typhimurium TA 1535/ pSK1002, NM2009, and NM3009, Gene and Chromosome Analysis (K. W. Adolph, ed.), Methods in Molecular Genetics Vol. 5, Academic Press, Orlando, FL, 1994, pp. 342-355.
35. H. Glatt, K. Pauly, A. Czich, J. L. Falany, and C. N. Falany, Activation of benzylic alcohols to mutagens by rat and human sulfotransferases expressed in Escherichia coli, Eur. J. Pharmacol., 293, 173-181 (1995).
36. 7-guanyl)ethyl]glutathione as a mutagenic lesion formed from ethylene dibromide, J. Biol. Chem., 267, 6672-6679 (1992).
37. D. M. Grant, P. D. Josephy, H. L. Lord, and L. D. Morrison, Salmonella typhimurium strains expressing human arylamine N-acetyltransferases: Metabolism and mutagenic activation of aromatic amines, Cancer Res., 52, 3961-3964 (1992).
38. E. M. J. Gillam, L. M. Notley, D. Kim, R. G. Mundkowski, A. M. Aguinaldo, A. Volkov, F. H. Arnold, P. Soucek, J. DeVoss, and F. P. Guengerich, Formation of indigo by recombinant human cytochrome P450, Biochem. Biophys. Res. Commun., 265, 469-472 (1999).
39. H. Bialy, Biotechnology, bioremediation, and blue genes, Nature Biotechnol., 15, 110 (1997).
40. G. A. Russell and G. Kaupp, Oxidation of carbanions. IV. Oxidation of indoxyl to indigo in basic solution, J. Am. Chem. Soc., 91, 3851-3859 (1969).
41. 14C]indole in the rat, Biochem. J., 98, 266-277 (1966).
42. J. D. Sapira, S. Somani, A. P. Shapiro, E. T. Scheib, and W. Reihl, Mammalian indoxyl metabolism and its relation to the formation of urinary indigo pigments, Metab. Clin. Exp. 20, 474-486 (1971).